Trials / Completed
CompletedNCT00503126
Bivalirudin as a Procedural Anticoagulant in Pediatrics
Bivalirudin (Angiomax®) As A Procedural Anticoagulant In The Pediatric Population Undergoing Intravascular Procedures For Congenital Heart Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- The Medicines Company · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Pharmacokinetics and safety of weight based bivalirudin in children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bivalirudin | anticoagulation |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2007-07-18
- Last updated
- 2011-11-10
Source: ClinicalTrials.gov record NCT00503126. Inclusion in this directory is not an endorsement.